715 related articles for article (PubMed ID: 22267580)
1. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR.
Liu JJ; Horst R; Katritch V; Stevens RC; Wüthrich K
Science; 2012 Mar; 335(6072):1106-10. PubMed ID: 22267580
[TBL] [Abstract][Full Text] [Related]
2. Simulations of biased agonists in the β(2) adrenergic receptor with accelerated molecular dynamics.
Tikhonova IG; Selvam B; Ivetac A; Wereszczynski J; McCammon JA
Biochemistry; 2013 Aug; 52(33):5593-603. PubMed ID: 23879802
[TBL] [Abstract][Full Text] [Related]
3. Biased Signaling of the G-Protein-Coupled Receptor β
Lamichhane R; Liu JJ; White KL; Katritch V; Stevens RC; Wüthrich K; Millar DP
Structure; 2020 Mar; 28(3):371-377.e3. PubMed ID: 31978323
[TBL] [Abstract][Full Text] [Related]
4. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
5. β
Eddy MT; Didenko T; Stevens RC; Wüthrich K
Structure; 2016 Dec; 24(12):2190-2197. PubMed ID: 27839952
[TBL] [Abstract][Full Text] [Related]
6. The β-blocker Nebivolol Is a GRK/β-arrestin biased agonist.
Erickson CE; Gul R; Blessing CP; Nguyen J; Liu T; Pulakat L; Bastepe M; Jackson EK; Andresen BT
PLoS One; 2013; 8(8):e71980. PubMed ID: 23977191
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
8. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
9. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.
Wisler JW; DeWire SM; Whalen EJ; Violin JD; Drake MT; Ahn S; Shenoy SK; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16657-62. PubMed ID: 17925438
[TBL] [Abstract][Full Text] [Related]
10. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.
Rasmussen SG; Choi HJ; Fung JJ; Pardon E; Casarosa P; Chae PS; Devree BT; Rosenbaum DM; Thian FS; Kobilka TS; Schnapp A; Konetzki I; Sunahara RK; Gellman SH; Pautsch A; Steyaert J; Weis WI; Kobilka BK
Nature; 2011 Jan; 469(7329):175-80. PubMed ID: 21228869
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of β-arrestin 1 and 2 to the β2-adrenoceptor: analysis of 65 ligands.
Littmann T; Göttle M; Reinartz MT; Kälble S; Wainer IW; Ozawa T; Seifert R
J Pharmacol Exp Ther; 2015 Nov; 355(2):183-90. PubMed ID: 26306764
[TBL] [Abstract][Full Text] [Related]
12. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling.
Manglik A; Kim TH; Masureel M; Altenbach C; Yang Z; Hilger D; Lerch MT; Kobilka TS; Thian FS; Hubbell WL; Prosser RS; Kobilka BK
Cell; 2015 May; 161(5):1101-1111. PubMed ID: 25981665
[TBL] [Abstract][Full Text] [Related]
13. 1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1.
Smith KJ; Baillie GS; Hyde EI; Li X; Houslay TM; McCahill A; Dunlop AJ; Bolger GB; Klussmann E; Adams DR; Houslay MD
Cell Signal; 2007 Dec; 19(12):2612-24. PubMed ID: 17900862
[TBL] [Abstract][Full Text] [Related]
14. Structural features of β2 adrenergic receptor: crystal structures and beyond.
Bang I; Choi HJ
Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
[TBL] [Abstract][Full Text] [Related]
15. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
[TBL] [Abstract][Full Text] [Related]
16. Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.
Granier S; Kim S; Shafer AM; Ratnala VR; Fung JJ; Zare RN; Kobilka B
J Biol Chem; 2007 May; 282(18):13895-905. PubMed ID: 17347144
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK
Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells.
Peitzman ER; Zaidman NA; Maniak PJ; O'Grady SM
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(1):L50-8. PubMed ID: 26566905
[TBL] [Abstract][Full Text] [Related]
19. Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.
Kim IM; Tilley DG; Chen J; Salazar NC; Whalen EJ; Violin JD; Rockman HA
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14555-60. PubMed ID: 18787115
[TBL] [Abstract][Full Text] [Related]
20. Insight into partial agonism by observing multiple equilibria for ligand-bound and G
Solt AS; Bostock MJ; Shrestha B; Kumar P; Warne T; Tate CG; Nietlispach D
Nat Commun; 2017 Nov; 8(1):1795. PubMed ID: 29176642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
